Glycomine (Series A)

Funding Details
Awarder
Inbox
Date Award
November 16, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$12,000,000

Company Info
Founders
Peter McWilliams
Company Description
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Market
Orphan drugs for rare monogenic disorders
Location
San Carlos, California, USA
Coinvestors
Chiesi Ventures, Sanderling Ventures

Links